TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2010

Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy.

José Baselga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.